Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapyUri Kopylov, David Drobne, Triana Lobatón et al.|Alimentary Pharmacology & Therapeutics|2020Cited by 80
Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab CohortNikolas Plevris, Charlie W. Lees, Wai Liam Lam et al.|Journal of Crohn s and Colitis|2019Cited by 51